10q10k10q10k.net
SI-BONE, Inc.

SI-BONE, Inc.SIBNEarnings & Financial Report

Nasdaq · industrial manufacturing

Bone Clones, Inc. manufactures, distributes, and sells osteological reproductions of human and animal bones. Located in Chatsworth, California, Bone Clones provides these reproductions to museums, universities, medical schools, and other educational institutions.

SIBN Q3 2025 Key Financial Metrics

Revenue

$48.7M

Gross Profit

$38.8M

Operating Profit

$-5.4M

Net Profit

$-4.6M

Gross Margin

79.8%

Operating Margin

-11.1%

Net Margin

-9.4%

YoY Growth

20.6%

EPS

$-0.11

Financial Flow

SI-BONE, Inc. Q3 2025 Financial Summary

SI-BONE, Inc. reported revenue of $48.7M for Q3 2025, with a net profit of $-4.6M (-9.4% margin). Cost of goods sold was $9.8M, operating expenses totaled $44.2M.

Key Financial Metrics

Total Revenue$48.7M
Net Profit$-4.6M
Gross Margin79.8%
Operating Margin-11.1%
Report PeriodQ3 2025

SI-BONE, Inc. Annual Revenue by Year

SI-BONE, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $167.2M).

YearAnnual Revenue
2024$167.2M
2023$138.9M
2022$106.4M

Income Statement

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Revenue$38.9M$37.9M$40.0M$40.3M$49.0M$47.3M$48.6M$48.7M
YoY Growth21.6%15.8%20.0%18.6%26.1%24.9%21.7%20.6%

Balance Sheet

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Assets$230.4M$223.7M$223.8M$227.0M$230.4M$227.3M$230.9M$234.3M
Liabilities$61.0M$58.2M$59.1M$62.0M$63.5M$60.0M$60.6M$62.1M
Equity$169.4M$165.5M$164.7M$165.0M$167.0M$167.3M$170.3M$172.1M

Cash Flow

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Operating CF$-2.3M$-7.6M$-6.3M$302000$1.2M$-4.9M$173000$2.3M